Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-6,page-paged-6,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.5.0,vc_responsive

CLIENT NEWS

 

 

  • Atriva Therapeutics Doses First Patient in Phase II RESPIRE trial in COVID-19
    www.atriva-therapeutics.com
  • Newron announces AGM 2021 result
    www.newron.com
  • LINDIS Biotech Reports Successful Initiation of Clinical Phase I Dose Escalation Study with the Trifunctional Antibody CATUMAXOMAB for Treatment of Non-Muscle-Invasive Bladder Cancer
    www.lindisbiotech.com
  • Last Patient Completes Marinomed Biotech AG’s Phase II Clinical Trial of Tacrosolv to Treat Ocular Hay Fever Symptoms
    www.marinomed.com
  • RedHill Biopharma’s Phase 2/3 COVID-19 Study of Opaganib Passes Fourth DSMB Review with Unanimous Recommendation to Continue
    www.redhillbio.com
  • Relief Engages Jan-Jaap Scherpbier of Sonsbeek Pharma Consultancy B.V. as Manufacturing and Supply Chain Consultant
    www.relieftherapeutics.com
  • Relief Reports that NeuroRx has Announced that Aviptadil has been Selected for Inclusion in NIH-Sponsored Global Clinical Trial which Includes Aviptadil and Remdesivir
    www.relieftherapeutics.com
  • Newron announces results of explanatory studies with evenamide in healthy volunteers and patients with schizophrenia
    www.newron.com
  • Abivax reports 2020 financial results and operations update (news with additional features)
    www.abivax.com
  • Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
    www.rentschler-biopharma.com